antihypertensive agents

Preferred Label : antihypertensive agents;

MeSH definition : Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.;

MeSH synonym : anti hypertensive drugs; agents, antihypertensive; antihypertensives; anti hypertensive agents; drugs, anti-hypertensive; anti-hypertensives; antihypertensive drugs; anti-hypertensive drugs; anti hypertensives; drugs, antihypertensive; anti-hypertensive agents; agents, anti-hypertensive; Antihypertensive Agent; Agent, Antihypertensive; Anti-Hypertensive Agent; Agent, Anti-Hypertensive; Anti Hypertensive Agent; Anti-Hypertensive Drug; Anti Hypertensive Drug; Drug, Anti-Hypertensive; Antihypertensive Drug; Drug, Antihypertensive; Anti-Hypertensive; Anti Hypertensive; Antihypertensive;

MeSH annotation : not for ocular hypertension;

Wikipedia link : https://en.wikipedia.org/wiki/Antihypertensive drug;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000959;

UMLS CUI

C0003364;

ATC code(s)
- cloranolol [ATC Code]
- rauwolfia alkaloids, whole root [ATC Code]
- secondary and tertiary amines [ATC Code]
- sitaxentan [ATC Code]
ATC code(s)
- Beta blocking agents, other combinations [ATC Code]
- alkaloids, excl. rauwolfia [ATC Code]
- alpha-adrenoreceptor antagonists [ATC Code]
- ambrisentan [ATC Code]
- antiadrenergic agents, ganglion-blocking [ATC Code]
- antihypertensives [ATC Code]
- antihypertensives and diuretics in combination [ATC Code]
- betanidine [ATC Code]
- bisquaternary ammonium compounds [ATC Code]
- bosentan [ATC Code]
- cadralazine [ATC Code]
- clonidine [ATC Code]
- combinations of antihypertensives in atc-gr. c02 [ATC Code]
- combinations of rauwolfia alkaloids [ATC Code]
- combinations of rauwolfia alkoloids, combinations [ATC Code]
- debrisoquine [ATC Code]
- diazoxide [ATC Code]
- doxazosin [ATC Code]
- endralazine [ATC Code]
- guanazodine [ATC Code]
- guanfacine [ATC Code]
- guanidine derivatives [ATC Code]
- guanidine derivatives [ATC Code]
- guanoclor [ATC Code]
- guanoxabenz [ATC Code]
- guanoxan [ATC Code]
- indoramin [ATC Code]
- ketanserin [ATC Code]
- mecamylamine [ATC Code]
- methyldopa [ATC Code]
- methyldopa (levorotatory) [ATC Code]
- methyldopa (racemic) [ATC Code]
- metirosine [ATC Code]
- minoxidil [ATC Code]
- moxonidine [ATC Code]
- nitroferricyanide derivatives [ATC Code]
- nitroprusside [ATC Code]
- other antihypertensives and diuretics [ATC Code]
- pyrimidine derivatives [ATC Code]
- rauwolfia alkaloids [ATC Code]
- rauwolfia alkaloids and diuretics in combination [ATC Code]
- rauwolfia alkaloids, whole root [ATC Code]
- rilmenidine [ATC Code]
- secondary and tertiary amines [ATC Code]
- sulfonium derivatives [ATC Code]
- thiazide derivatives [ATC Code]
- tolonidine [ATC Code]
- trimazosin [ATC Code]
- trimetaphan [ATC Code]
- urapidil [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Antihypertensive agents [PASCAL theme]
- Antihypertensive drug [ICHI extension code]
CISMeF manual mappings
- Poisoning caused by antihypertensive agent (disorder) [Inactive SNOMED CT concept]
Indexing information
- 2-(1H-indazole-5-yl)amino-4-methoxy-6-piperazinotriazine [MeSH Supplementary Concept]
- 7-(biphenyl-4-yl)-3,4,8,9-tetrahydro-2H-pyridazino(1,6-a)(1,3,5)triazin-2-imine [MeSH Supplementary Concept]
- AR-12286 [MeSH Supplementary Concept]
- aliskiren [MeSH Supplementary Concept]
- allisartan isoproxil [MeSH Supplementary Concept]
- azarga [MeSH Supplementary Concept]
- diethyl 2,6-dimethyl-4-(2-(3-oxo-3-(tert-pentyloxy)prop-1-enyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate [MeSH Supplementary Concept]
- duotrav [MeSH Supplementary Concept]
- ganfort [MeSH Supplementary Concept]
- vinpocetine [MeSH Supplementary Concept]
- xalacom [MeSH Supplementary Concept]
MedlinePlus topic(s)
- blood pressure medicines [MedlinePlus Topic]
Record concept(s)
- antihypertensive agents [MeSH concept]
See also
- adrenergic alpha-antagonists [MeSH Descriptor]
- adrenergic beta-antagonists [MeSH Descriptor]
- angiotensin-converting enzyme inhibitors [MeSH Descriptor]
- calcium channel blockers [MeSH Descriptor]
- diuretics [MeSH Descriptor]
- ganglionic blockers [MeSH Descriptor]
- hypertension [MeSH Descriptor]
- vasodilator agents [MeSH Descriptor]
See also inter- (CISMeF)
- Hypotensive agent (substance) [SNOMED CT concept]
- central antihypertensive agents [CISMeF Querying Strategy]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea [MeSH Supplementary Concept]
- 1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine [MeSH Supplementary Concept]
- 1-hexadecyl-2-acetyl-glycero-3-phosphocholine [MeSH Supplementary Concept]
- 1-sarcosine-8-isoleucine angiotensin ii [MeSH Descriptor]
- 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine [MeSH Supplementary Concept]
- 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer [MeSH Descriptor]
- 3-nitropropionic acid [MeSH Supplementary Concept]
- 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide [MeSH Supplementary Concept]
- AE0047 [MeSH Supplementary Concept]
- Amlodipine Besylate, Olmesartan Medoxomil Drug Combination [MeSH Descriptor]
- Amlodipine, Valsartan Drug Combination [MeSH Descriptor]
- BQ 22-708 [MeSH Supplementary Concept]
- BQ 788 [MeSH Supplementary Concept]
- Bimatoprost [MeSH Descriptor]
- Bosentan [MeSH Descriptor]
- Brimonidine Tartrate [MeSH Descriptor]
- Carvedilol [MeSH Descriptor]
- Eplerenone [MeSH Descriptor]
- FK 409 [MeSH Supplementary Concept]
- Irbesartan [MeSH Descriptor]
- L 158809 [MeSH Supplementary Concept]
- L-proline, N2-((1S)-1-carboxy-3-phenylpropyl)-N6-((4-hydroxyphenyl)iminomethyl)-L-lysyl- [MeSH Supplementary Concept]
- Latanoprost [MeSH Descriptor]
- N(1),N(11)-diethylnorspermine [MeSH Supplementary Concept]
- N(1),N(14)-bis(ethyl)homospermine [MeSH Supplementary Concept]
- N,N-di-n-propyldopamine [MeSH Supplementary Concept]
- N-cyano-N'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate [MeSH Supplementary Concept]
- NIP 121 [MeSH Supplementary Concept]
- Nebivolol [MeSH Descriptor]
- Olmesartan Medoxomil [MeSH Descriptor]
- Quinapril [MeSH Descriptor]
- Rilmenidine [MeSH Descriptor]
- Telmisartan [MeSH Descriptor]
- Terlipressin [MeSH Descriptor]
- Torsemide [MeSH Descriptor]
- Travoprost [MeSH Descriptor]
- Valsartan [MeSH Descriptor]
- Y 26763 [MeSH Supplementary Concept]
- Y 27632 [MeSH Supplementary Concept]
- acebutolol [MeSH Descriptor]
- acebutolol, nifedipine drug combination [MeSH Supplementary Concept]
- adrenomedullin [MeSH Descriptor]
- alacepril [MeSH Supplementary Concept]
- alprenolol [MeSH Descriptor]
- ambrisentan [MeSH Supplementary Concept]
- amlodipine [MeSH Descriptor]
- amlodipine, atorvastatin drug combination [MeSH Supplementary Concept]
- amosulalol [MeSH Supplementary Concept]
- angiotensin I (1-7) [MeSH Supplementary Concept]
- aprikalim [MeSH Supplementary Concept]
- atenolol [MeSH Descriptor]
- atenolol, chlortalidone drug combinations [MeSH Supplementary Concept]
- atrial natriuretic factor prohormone (103-126) [MeSH Supplementary Concept]
- azepexole [MeSH Supplementary Concept]
- benazepril [MeSH Supplementary Concept]
- benazeprilat [MeSH Supplementary Concept]
- bendazole [MeSH Supplementary Concept]
- bendroflumethiazide [MeSH Descriptor]
- benoxathian [MeSH Supplementary Concept]
- bepridil [MeSH Descriptor]
- berbamine [MeSH Supplementary Concept]
- betaxolol [MeSH Descriptor]
- bethanidine [MeSH Descriptor]
- bietaserpine [MeSH Supplementary Concept]
- bimakalim [MeSH Supplementary Concept]
- bis(p-chlorophenyl)acetic acid [MeSH Supplementary Concept]
- bisoprolol [MeSH Descriptor]
- bisoprolol, hydrochlorothiazide drug combination [MeSH Supplementary Concept]
- bretylium tosylate [MeSH Descriptor]
- budralazine [MeSH Supplementary Concept]
- bupranolol [MeSH Descriptor]
- buthiazide [MeSH Supplementary Concept]
- cadralazine [MeSH Supplementary Concept]
- cafedrine [MeSH Supplementary Concept]
- candesartan [MeSH Supplementary Concept]
- candesartan cilexetil [MeSH Supplementary Concept]
- candoxatril [MeSH Supplementary Concept]
- captopril [MeSH Descriptor]
- captopril, hydrochlorothiazide drug combination [MeSH Supplementary Concept]
- carteolol [MeSH Descriptor]
- celiprolol [MeSH Descriptor]
- ceronapril [MeSH Supplementary Concept]
- chlorisondamine [MeSH Descriptor]
- chlorothiazide [MeSH Descriptor]
- chlorthalidone [MeSH Descriptor]
- cicletanine [MeSH Supplementary Concept]
- cilazapril [MeSH Descriptor]
- cilazaprilat [MeSH Supplementary Concept]
- clentiazem [MeSH Supplementary Concept]
- clonidine [MeSH Descriptor]
- clonidine, chlorthalidone drug combination [MeSH Supplementary Concept]
- clopamide, pindolol drug combination [MeSH Supplementary Concept]
- cromakalim [MeSH Descriptor]
- cyclo(Trp-Asp-Pro-Val-Leu) [MeSH Supplementary Concept]
- cyclopenthiazide [MeSH Descriptor]
- cyclothiazide [MeSH Supplementary Concept]
- dauricine [MeSH Supplementary Concept]
- debrisoquin [MeSH Descriptor]
- delapril [MeSH Supplementary Concept]
- diallyl disulfide [MeSH Supplementary Concept]
- diazoxide [MeSH Descriptor]
- dihydralazine [MeSH Descriptor]
- dihydroalprenolol [MeSH Descriptor]
- diltiazem [MeSH Descriptor]
- dorzolamide [MeSH Supplementary Concept]
- doxazosin [MeSH Descriptor]
- efonidipine [MeSH Supplementary Concept]
- enalapril [MeSH Descriptor]
- enalaprilat [MeSH Descriptor]
- epanolol [MeSH Supplementary Concept]
- epoprostenol [MeSH Descriptor]
- eprosartan [MeSH Supplementary Concept]
- essential 303 forte [MeSH Supplementary Concept]
- etozolin [MeSH Supplementary Concept]
- felodipine [MeSH Descriptor]
- fenoldopam [MeSH Descriptor]
- ferulic acid [MeSH Supplementary Concept]
- firibastat [MeSH Supplementary Concept]
- flesinoxan [MeSH Supplementary Concept]
- fosinopril [MeSH Descriptor]
- fosinoprilat [MeSH Supplementary Concept]
- grayanotoxin I [MeSH Supplementary Concept]
- guanabenz [MeSH Descriptor]
- guanadrel [MeSH Supplementary Concept]
- guanethidine [MeSH Descriptor]
- guanfacine [MeSH Descriptor]
- hexamethonium [MeSH Descriptor]
- hexamethonium compounds [MeSH Descriptor]
- hydralazine [MeSH Descriptor]
- hydrochlorothiazide [MeSH Descriptor]
- hydrochlorothiazide, lisinopril drug combination [MeSH Supplementary Concept]
- hydrochlorothiazide-triamterene [MeSH Supplementary Concept]
- hydroflumethiazide [MeSH Descriptor]
- imidapril [MeSH Supplementary Concept]
- indapamide [MeSH Descriptor]
- indapamide, perindopril drug combination [MeSH Supplementary Concept]
- indenolol [MeSH Supplementary Concept]
- indoramin [MeSH Descriptor]
- indorenate [MeSH Supplementary Concept]
- inositol nicotinate, mefruside, reserpine drug combination [MeSH Supplementary Concept]
- isopropyl unoprostone [MeSH Supplementary Concept]
- isradipine [MeSH Descriptor]
- kallidin [MeSH Descriptor]
- ketanserin [MeSH Descriptor]
- labetalol [MeSH Descriptor]
- lacidipine [MeSH Supplementary Concept]
- lercanidipine [MeSH Supplementary Concept]
- libenzapril [MeSH Supplementary Concept]
- linsidomine [MeSH Supplementary Concept]
- lisinopril [MeSH Descriptor]
- lofexidine [MeSH Supplementary Concept]
- losartan [MeSH Descriptor]
- losartan carboxylic acid [MeSH Supplementary Concept]
- manidipine [MeSH Supplementary Concept]
- mecamylamine [MeSH Descriptor]
- medroxalol [MeSH Supplementary Concept]
- medullipin I [MeSH Supplementary Concept]
- methyldopa [MeSH Descriptor]
- metipranolol [MeSH Descriptor]
- metolazone [MeSH Descriptor]
- metoprolol [MeSH Descriptor]
- mibefradil [MeSH Descriptor]
- minoxidil [MeSH Descriptor]
- moexipril [MeSH Supplementary Concept]
- monatepil [MeSH Supplementary Concept]
- moxonidine [MeSH Supplementary Concept]
- muzolimine [MeSH Descriptor]
- nadolol [MeSH Descriptor]
- naftopidil [MeSH Supplementary Concept]
- nicardipine [MeSH Descriptor]
- nicorandil [MeSH Descriptor]
- niguldipine [MeSH Supplementary Concept]
- nilvadipine [MeSH Supplementary Concept]
- nimodipine [MeSH Descriptor]
- nipradilol [MeSH Supplementary Concept]
- nisoldipine [MeSH Descriptor]
- nitrendipine [MeSH Descriptor]
- nitroprusside [MeSH Descriptor]
- oleuropein [MeSH Supplementary Concept]
- olmesartan [MeSH Supplementary Concept]
- omapatrilat [MeSH Supplementary Concept]
- oxprenolol [MeSH Descriptor]
- parathyroid hormone-related protein (1-34) [MeSH Supplementary Concept]
- pargyline [MeSH Descriptor]
- pempidine [MeSH Descriptor]
- penbutolol [MeSH Descriptor]
- pentolinium tartrate [MeSH Descriptor]
- perindopril [MeSH Descriptor]
- perindoprilat [MeSH Supplementary Concept]
- phenoxybenzamine [MeSH Descriptor]
- phentolamine [MeSH Descriptor]
- pinacidil [MeSH Descriptor]
- pindolol [MeSH Descriptor]
- piperoxan [MeSH Descriptor]
- polythiazide [MeSH Descriptor]
- prazosin [MeSH Descriptor]
- propranolol [MeSH Descriptor]
- protoveratrines [MeSH Descriptor]
- quinaprilat [MeSH Supplementary Concept]
- ramipril [MeSH Descriptor]
- ramiprilat [MeSH Supplementary Concept]
- remikiren [MeSH Supplementary Concept]
- rentiapril [MeSH Supplementary Concept]
- reserpine [MeSH Descriptor]
- ryodipine [MeSH Supplementary Concept]
- saprisartan potassium [MeSH Supplementary Concept]
- saralasin [MeSH Descriptor]
- scoparone [MeSH Supplementary Concept]
- selexipag [MeSH Supplementary Concept]
- sesamin [MeSH Supplementary Concept]
- spirapril [MeSH Supplementary Concept]
- talinolol [MeSH Supplementary Concept]
- telmisartan amlodipine combination [MeSH Supplementary Concept]
- temocapril hydrochloride [MeSH Supplementary Concept]
- teprotide [MeSH Descriptor]
- tetrahydropalmatine [MeSH Supplementary Concept]
- theodrenaline [MeSH Supplementary Concept]
- tibolone [MeSH Supplementary Concept]
- ticrynafen [MeSH Descriptor]
- timolol [MeSH Descriptor]
- tobanum [MeSH Supplementary Concept]
- tocopherylquinone [MeSH Supplementary Concept]
- todralazine [MeSH Descriptor]
- tolazoline [MeSH Descriptor]
- trandolapril [MeSH Supplementary Concept]
- treprostinil [MeSH Supplementary Concept]
- trichlormethiazide [MeSH Descriptor]
- trimazosin [MeSH Supplementary Concept]
- trimethaphan [MeSH Descriptor]
- urapidil [MeSH Supplementary Concept]
- veratrum alkaloids [MeSH Descriptor]
- vincamine [MeSH Descriptor]
- viprostol [MeSH Supplementary Concept]
- xipamide [MeSH Descriptor]
- zofenopril [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Antihypertensive Agent [NCIt concept]
- Antihypertensive agent [ACR pathology]
- Antihypertensive drug [ICD-11 Extension code]
- Antihypertensives [LOINC hierarchical part]
- Hypotensive agent (product) [SNOMED CT concept]
- Hypotensive agent (substance) [SNOMED CT concept]
- antihypertensives [ATC Code]
- blood pressure medicines [MedlinePlus Topic]
- hypotensive agent, nos [SNOMED Notion]
Validated automatic mappings to BTNT
- Antihypertensives for pulmonary arterial hypertension [ATC Code]
- other antihypertensives [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients